176 related articles for article (PubMed ID: 9505144)
21. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
[TBL] [Abstract][Full Text] [Related]
22. Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with polyanions, and involvement of interferon-gamma in the regulation of cytokine secretion.
Sorimachi K; Akimoto K; Hattori Y; Ieiri T; Niwa A
Cytokine; 1999 Aug; 11(8):571-8. PubMed ID: 10433803
[TBL] [Abstract][Full Text] [Related]
23. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.
Elner VM; Burnstine MA; Strieter RM; Kunkel SL; Elner SG
Exp Eye Res; 1997 Dec; 65(6):781-9. PubMed ID: 9441701
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma enhances tumor necrosis factor-alpha production by inhibiting early phase interleukin-10 transcription.
Shakhov AN; Woerly G; Car BD; Ryffel B
Eur Cytokine Netw; 1996 Dec; 7(4):741-50. PubMed ID: 9010676
[TBL] [Abstract][Full Text] [Related]
25. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
26. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
27. Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.
Schiller JH; Bittner G; Storer B; Willson JK
Cancer Res; 1987 Jun; 47(11):2809-13. PubMed ID: 3105867
[TBL] [Abstract][Full Text] [Related]
28. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
29. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Vairo G; Royston AK; Hamilton JA
J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337
[TBL] [Abstract][Full Text] [Related]
30. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
31. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
32. Priming the macrophage respiratory burst with IL-4: enhancement with TNF-alpha but inhibition by IFN-gamma.
Phillips WA; Croatto M; Hamilton JA
Immunology; 1990 Aug; 70(4):498-503. PubMed ID: 2118480
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.
Cox GW; Melillo G; Chattopadhyay U; Mullet D; Fertel RH; Varesio L
J Immunol; 1992 Nov; 149(10):3290-6. PubMed ID: 1431106
[TBL] [Abstract][Full Text] [Related]
34. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
35. IL-1beta and TNF-alpha, but not IFN-alpha, IFN-gamma, IL-6 or IL-8, are secretory mediators in human distal colon.
Bode H; Schmitz H; Fromm M; Scholz P; Riecken EO; Schulzke JD
Cytokine; 1998 Jun; 10(6):457-65. PubMed ID: 9632533
[TBL] [Abstract][Full Text] [Related]
36. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
Le JM; Vilcek J
J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms.
Sanceau J; Merlin G; Wietzerbin J
J Immunol; 1992 Sep; 149(5):1671-5. PubMed ID: 1387149
[TBL] [Abstract][Full Text] [Related]
38. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
39. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.
Hahn T; Barak Y; Liebovich E; Malach L; Dagan O; Rubinstein E
Exp Hematol; 1991 Mar; 19(3):157-60. PubMed ID: 1899831
[TBL] [Abstract][Full Text] [Related]
40. The suppression of lipoprotein lipase expression in J774.2 macrophages by IFN-gamma and TNF-alpha is mediated at the transcriptional level.
Muhammad TS; Hughes TR; Cryer A; Ramji DP
Biochem Soc Trans; 1998 Feb; 26(1):S12. PubMed ID: 10909770
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
